| |
| Issue |
Title |
| |
| No 2 (2024) |
Socio-economic burden of chronic graft-versus-host disease after allogenic bone marrow transplantation |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Ju. E. Balykina |
| |
| No 4 (2023) |
Economic analysis of the use of drugs for the treatment of hemophilia A, B and Willebrand's disease |
Abstract
PDF (Rus)
|
|
D. S. Fokina, O. V. Zhukova, A. L. Khokhlov, S. A. Volkova |
| |
| No 4 (2023) |
Clinical-economic evaluation of distance education and blood glucose level monitoring in adults with diabetes mellitus |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, V. K. Fediaeva |
| |
| No 4 (2023) |
Pharmacoeconomic study of the effectiveness of cytogenetic studies in patients with MM before prescribing first-line therapy |
Abstract
PDF (Rus)
|
|
Yu. A. Zabolotneva, I. S. Krysanov |
| |
| No 3 (2023) |
An economic evaluation of vaccination in children against meningococcal infection in Moscow |
Abstract
PDF (Rus)
|
|
S. V. Svetlichnaya, L. N. Mazankova, L. D. Popovich, L. A. Elagina |
| |
| No 2 (2023) |
Economic aspects of the fixed combinations of lipid lowering medicines in group risks patients |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, M. Yu. Frolov, E. A. Luchinin, K. A. Kokushkin, E. D. Laryushkina, T. R. Kameneva, E. V. Kuznetsova |
| |
| No 2 (2023) |
Socio-economic burden of atrial fibrillation in the Russian Federation: dynamics over 12 years |
Abstract
PDF (Rus)
|
|
A. P. Kasimova, O. S. Tufanova, A. S. Kolbin |
| |
| No 2 (2023) |
Drugs influencing on PCSK9 activity: modelling of efficacy in patients who had myocardial infarction with uncontrolled dyslipidemia |
Abstract
PDF (Rus)
|
|
V. I. Ignatyeva, A. V. Kontsevaya, O. M. Drapkina, E. V. Derkach |
| |
| No 4 (2022) |
Optimization of laboratory support costs in a multidisciplinary hospital: possible solutions. Emphasis on the medical information system |
Abstract
PDF (Rus)
|
|
A. S. Fedorenko, A. T. Burbello, L. B. Gaikova, E. A. Orishak, E. L. Lataria, O. V. Granatovich, M. V. Pokladova, M. A. Korosteleva |
| |
| No 3 (2022) |
Updated guidelines of reporting pharmacoeconomics and health technology assessment results from 2022 ISPOR (CHEERS 2022) |
Abstract
PDF (Rus)
|
|
M. A. Truuts, A. A. Kurilev, A. S. Kolbin |
| |
| No 2 (2022) |
Economic prognosis from vaccination against meningococcal infection inclusion into the National calendar of prophylactic vaccines in children of first age old |
Abstract
PDF (Rus)
|
|
L. D. Popovich, D. A. Vakhrusheva, S. V. Svetlichnaya |
| |
| No 1 (2022) |
Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, G. V. Kukushkin, E. V. Luchinina, T. V. Shelekhova, T. R. Kameneva, E. V. Kuznetsova, E. A. Luchinin |
| |
| No 3 (2021) |
Optimization of chronic lymphocytic leukemia treatment using game theory |
Abstract
PDF (Rus)
|
|
A. S. Luchinin, V. V. Strugov |
| |
| No 3 (2021) |
Health technology assessment: factors affecting the results |
Abstract
PDF (Rus)
|
|
I. N. Kozhanova |
| |
| No 3 (2021) |
Clinical and economic aspects of the use of OneTouch glucose meters for the screening of diabetes mellitus |
Abstract
PDF (Rus)
|
|
A. E. Cheberda, D. Yu. Belousov |
| |
| No 1 (2021) |
Resource consumption and patient employability during systemic therapy and biological therapy |
Abstract
PDF (Rus)
|
|
L. S. Kruglova, A. A. Hotko |
| |
| No 4 (2019) |
Hospital-based health technology assessment in Russian Federation: opportunities and prospects |
Abstract
PDF (Rus)
|
|
Y. M. Gomon |
| |
| No 4 (2019) |
Clostridium difficile associated infection: view of hospital-based health technology assessment |
Abstract
PDF (Rus)
|
|
Y. M. Gomon |
| |
| No 2 (2018) |
Multicriteria analysis of the assortment of innovative drugs in oncohematology as a tool for supporting decision-making in the field of drug provision |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova, E. A. Popova |
| |
| No 1 (2014) |
Health technology assessment of hyaluronans in osteoarthritis treatment |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin |
| |
| No 2 (2015) |
Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices - Modeling Studies |
Abstract
PDF (Rus)
|
|
M. C. Weinstein, Bernie O’Brien, John Hornberger, Joseph Jackson, Magnus Johannesson, Chris Mccabe, Bryan R. Luce, A. V. Pavlysh, A. S. Kolbin |
| |
| No 2 (2015) |
Multinational Trials - Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force Report |
Abstract
PDF (Rus)
|
|
Diane Wild, Sonya Eremenco, Isabelle Mear, Mona Martin, Caroline Houchin, Mary Gawlicki, Asha Hareendran, Ingela Wiklund, Lee Yee Chong, Robyn Von Maltzahn, Lawrence Cohen, Elizabeth Molsen, A. V. Pavlysh, E. V. Verbitskaya |
| |
| No 2 (2015) |
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR Good Research Practices for the Assessment of Patient-Reported Outcomes in Children and Adolescents Task Force |
Abstract
PDF (Rus)
|
|
Louis S. Matza, Donald L. Patrick, Anne W. Riley, John J. Alexander, Luis Rajmil, Andreas M. Pleil, Monika Bullinger, , , |
| |
| No 3 (2015) |
Cost minimization analysis of using «Ethanol wipes «МК Aseptic»» |
Abstract
PDF (Rus)
|
|
D. Yu. Belousov, E. V. Afanasyeva |
| |
| 1 - 24 of 24 Items |
|
